The company applied for and won assistance from the NRC’s Industrial Research Assistance Program for production scale-up of its line of omega-3 products.
The infusion of cash and counsel will pave the way for the company to begin commercial quantity production of its plant-based omega-3 products, the company said in a statement.
READ: LeanLife Health stock climbs after its Omega-3 product wins pure stamp from global testing authority SGS
LeanLife’s products are derived from flaxseed oil, which provides the highest concentration of omega-3 of any plant and offers a two-year shelf life. The higher ratio of omega-3 to omega-6 fats in LeanLife’s oils offers health benefits, the company said.
The NRC IRAP’s mission is to grease the wheel for small and medium Candian technology companies by providing funding and innovation services.
"The validation by an expert of the company's management team, proprietary technology and market potential, and selection after a competitive process, once again demonstrates the strength of LeanLife Health,” CEO Stan Lis told investors. “It is an indirect endorsement of the company's potential."
Contact Andrew Kessel at [email protected]
Follow him on Twitter @andrew_kessel